Zobrazit minimální záznam

dc.contributor.authorRoman, Jan
dc.contributor.authorJalůvka, František
dc.contributor.authorOstruszka, Petr
dc.contributor.authorJelínek, Petr
dc.contributor.authorHrubovčák, Ján
dc.contributor.authorHavránek, Pavel
dc.contributor.authorVrtková, Adéla
dc.contributor.authorLys, Zdeněk
dc.contributor.authorDědochová, Jarmila
dc.contributor.authorProcházka, Václav
dc.date.accessioned2022-10-04T05:38:41Z
dc.date.available2022-10-04T05:38:41Z
dc.date.issued2022
dc.identifier.citationMedical Science Monitor. 2022, vol. 28, art. no. e936877.cs
dc.identifier.issn1643-3750
dc.identifier.urihttp://hdl.handle.net/10084/148671
dc.description.abstractBackground: Kidney donation after circulatory death (DCD) follows confirmation of death using cardiorespiratory criteria, while donation after brain death (DBD) uses neurological criteria. DBD and DCD donors are the main sources of grafts for transplantation. This retrospective cohort study from a single center in the Czech Republic aimed to compare 5-year post-transplantation outcomes after DCD and DBD transplantation without pre-mortem heparin administration. Material/Methods: A total of 227 recipients with matched donors enrolled in the transplantation program at our institution between 2015 and 2019 were analyzed. Following the application of the inclusion criteria, 99 recipients and 94 matched donors were finally included in the study. Results: The duration of cold ischemia (median 961 vs 1100 min, P=0.028) and the perfusion with the preservation solution (median 11 vs 22 min, P<0.001) was statistically significantly shorter in DBD than in DCD grafts. The 1-year survival rates were 97.5% (95% CI 94.1-100.0%) and 90.0% (95% CI: 77.8-100.0%) for DBD and DCD recipients, respectively. The 3-year survival rates were 91.9 (95% CI: 86.0-98.4) and 90.0 (95% CI: 77.8-100.0) for the DBD and DCD groups, respectively. The overall difference in survival between the 2 groups of patients was not statistically significant (P=0.750) nor was disease-free survival (P=0.370). Conclusions: This retrospective study from a single center showed similar 5-year results after kidney transplantation for DCD and DBD donors without pre-mortem heparin administration, including the time to graft failure and patient survival.cs
dc.language.isoencs
dc.publisherInternational Scientific Informationcs
dc.relation.ispartofseriesMedical Science Monitorcs
dc.relation.urihttps://doi.org/10.12659/MSM.936877cs
dc.rights© Med Sci Monit, 2022cs
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/cs
dc.subjectallograftscs
dc.subjectkidney diseasescs
dc.subjectkidney transplantationcs
dc.subjectorgan transplantationcs
dc.subjectrenal insufficiencycs
dc.titlePost-kidney transplantation results after circulatory or brain death without pre-mortem heparin administrationcs
dc.typearticlecs
dc.identifier.doi10.12659/MSM.936877
dc.rights.accessopenAccesscs
dc.type.versionpublishedVersioncs
dc.type.statusPeer-reviewedcs
dc.description.sourceWeb of Sciencecs
dc.description.volume28cs
dc.description.firstpageart. no. e936877cs
dc.identifier.wos000827713200001


Soubory tohoto záznamu

Tento záznam se objevuje v následujících kolekcích

Zobrazit minimální záznam

© Med Sci Monit, 2022
Kromě případů, kde je uvedeno jinak, licence tohoto záznamu je © Med Sci Monit, 2022